These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4070320)

  • 21. Effects of bezafibrate on HDL2/HDL3 ratio in postmenopausal hypertriglyceridemic women.
    Ushiroyama T; Sakuma K; Nosaka S
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):142-8. PubMed ID: 16891292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects.
    Heller F; Harvengt C
    Eur J Clin Pharmacol; 1983; 25(1):57-63. PubMed ID: 6617725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
    Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diurnal triglyceride profiles in 30 young healthy men as a function of diet, fasting triglyceride levels, body composition and insulin sensitivity].
    van Oostrom AJ; Castro Cabezas M; Harmelink MJ; Twickler TB; Remijnse TA; Erkelens DW
    Ned Tijdschr Geneeskd; 1999 Sep; 143(37):1868-72. PubMed ID: 10526601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs.
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Artery; 1980; 8(2):113-9. PubMed ID: 7458676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
    Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
    Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clofibrate treatment of hyperlipidemia in chronic renal failure.
    di Giulio S; Boulu R; Drüeke T; Nicolaĭ A; Zingraff J; Crosnier J
    Clin Nephrol; 1977 Dec; 8(6):504-9. PubMed ID: 598055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lipid-lowering effect of bezafibrate in patients with diabetes mellitus and hyperlipidaemia (author's transl)].
    Wahl P; Hasslacher C; Lang PD; Vollmar J
    Dtsch Med Wochenschr; 1978 Aug; 103(31):1233-7. PubMed ID: 668570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters.
    Vessby B; Lithell H; Hellsing K; Ostlund-Lindqvist AM; Gustafsson IB; Boberg J; Ledermann H
    Atherosclerosis; 1980 Oct; 37(2):257-69. PubMed ID: 7000090
    [No Abstract]   [Full Text] [Related]  

  • 31. [Improvement in diabetes control by treatment with bezafibrate].
    Rüth E; Vollmar J
    Dtsch Med Wochenschr; 1982 Oct; 107(39):1470-3. PubMed ID: 6749468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin and clofibrate in maturity onset diabetes mellitus: advantages of combined treatment.
    De Silva SR; Betteridge DJ; Shawe JE; Cudworth AG; Alberti KG
    Diabete Metab; 1979 Sep; 5(3):223-9. PubMed ID: 574098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of uremic hypertriglyceridaemia with bezafibrate.
    Norbeck HE; Anderson P
    Atherosclerosis; 1982 Aug; 44(2):125-36. PubMed ID: 7138614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind comparison of bezafibrate versus placebo in male volunteers with hyperlipoproteinemia.
    Bradford RH; Goldberg AC; Schonfeld G; Knopp RH
    Atherosclerosis; 1992 Jan; 92(1):31-40. PubMed ID: 1575820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of bezafibrate on plasma lipoproteins, biliary lipids and fecal sterols in healthy men.
    Kohlmeier M; Hill T; Remer P; Schlierf G
    Atherosclerosis; 1986 Apr; 60(1):29-35. PubMed ID: 3707671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diurnal variation in biliary lipids and serum VLDL before and during treatment with cloribrate.
    Andersén E; Hellström K
    Atherosclerosis; 1982 Jan; 41(1):87-97. PubMed ID: 7200365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of clofibrate and bezafibrate on cholesterol metabolism in the liver of the male rat.
    Shand JH; West DW
    Lipids; 1994 Nov; 29(11):747-52. PubMed ID: 7869854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trial.
    Koopal C; Marais AD; Westerink J; van der Graaf Y; Visseren FLJ
    J Lipid Res; 2017 Nov; 58(11):2180-2187. PubMed ID: 28928170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia.
    Hoogwerf BJ; Peters JR; Frantz ID; Hunninghake DB
    Metabolism; 1985 Oct; 34(10):978-81. PubMed ID: 4046841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of bezafibrate on lipoprotein (a) and triglyceride-rich lipoproteins, including intermediate-density lipoproteins, in patients with chronic renal failure receiving haemodialysis.
    Pelegrí A; Romero R; Sentí M; Nogués X; Pedro-Botet J; Rubiés-Prat J
    Nephrol Dial Transplant; 1992; 7(7):623-6. PubMed ID: 1323073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.